FDA: Young-Blood Transfusions Provide ‘No Proven Clinical Benefit’ for Aging, Alzheimer’s

February 19, 2019

(STAT News) – The quest to rejuvenate aging people with the blood of young donors has generated paying customers, captured the popular imagination, and, now, prompted a warning from the Food and Drug Administration. The agency on Tuesday said in a statement that plasma infusions from young people provide “no proven clinical benefit” against normal aging, Alzheimer’s disease, or a host of other diseases — despite a surge in their promotion for those purposes.

Recommended Reading